| 14 May, 04:55 pm | — | … | Senores Pharmaceuticals Limited has informed the Exchange about Investor Presentation | nse |
| 14 May, 03:59 pm | — | … | Senores Pharmaceuticals Ltd - 544319 - Submission Of Statement Of Deviation Or Variation In Utilisation Of Funds Of Public Issue For Quarter Ended On March 31, 2026 | bse |
| 14 May, 03:53 pm | — | … | Senores Pharmaceuticals Limited has informed the Exchange about statement of deviation(s) or variation(s) under Reg. 32 | nse |
| 14 May, 03:27 pm | — | … | Senores Pharmaceuticals Ltd - 544319 - Announcement under Regulation 30 (LODR)-Monitoring Agency Report | bse |
| 14 May, 03:25 pm | — | … | Senores Pharmaceuticals Limited has informed the Exchange regarding Monitoring Agency Report for the quarter ended March 31, 2026. | nse |
| 14 May, 02:31 pm | — | … | Senores Pharmaceuticals Ltd - 544319 - Announcement under Regulation 30 (LODR)-Press Release / Media Release | bse |
| 14 May, 02:28 pm | — | … | Senores Pharmaceuticals Limited has informed the Exchange regarding the media release in relation to the Audited Consolidated and Standalone financial results of the Company for the quarter and financial year ended March 31, 2026 | nse |
| 14 May, 02:20 pm | — | … | Senores Pharmaceuticals Ltd - 544319 - Financial Results For Quarter And Financial Year Ended March 31, 2026 | bse |
| 14 May, 02:11 pm | — | … | Senores Pharmaceuticals Limited has informed the Exchange regarding Outcome of Board Meeting held on May 14, 2026. | nse |
| 14 May, 02:09 pm | — | … | Senores Pharmaceuticals Limited has informed the Exchange regarding outcome of Board Meeting held on May 14, 2026 | nse |
| 08 May, 05:08 pm | — | … | Senores Pharmaceuticals Ltd - 544319 - Board Meeting Intimation for Considering And Approving The Audited Consolidated And Standalone Financial Results Of The Company For The Quarter And Financial Year Ended March 31, 2026 And To Transact Other Business Matters | bse |
| 29 Apr, 04:23 pm | — | … | Senores Pharmaceuticals Ltd - 544319 - Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A | bse |
| 22 Apr, 05:25 pm | — | … | Senores Pharmaceuticals Limited has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. | nse |
| 03 Apr, 08:01 pm | — | … | Senores Pharmaceuticals Limited has informed the Exchange regarding media release | nse |
| 03 Apr, 08:00 pm | — | … | Senores Pharmaceuticals Ltd - 544319 - Announcement under Regulation 30 (LODR)-Press Release / Media Release | bse |
| 03 Apr, 07:41 pm | — | … | Senores Pharmaceuticals Limited has informed the Exchange regarding intimation under Regulation 30 of SEBI (LODR) Regulations, 2015 | nse |
| 03 Apr, 07:40 pm | — | … | Senores Pharmaceuticals Ltd - 544319 - Announcement under Regulation 30 (LODR)-Acquisition | bse |
| 01 Apr, 05:23 pm | — | … | Senores Pharmaceuticals Ltd - 544319 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 | bse |
| 28 Mar, 12:56 pm | — | … | Senores Pharmaceuticals Limited has informed the Exchange regarding allotment of 1170000 Convertible Equity Warrants | nse |
| 28 Mar, 12:53 pm | — | … | Senores Pharmaceuticals Ltd - 544319 - Announcement under Regulation 30 (LODR)-Allotment | bse |
| 28 Mar, 12:52 pm | — | … | Senores Pharmaceuticals Limited has informed the Exchange regarding Outcome of Board Meeting held on March 28, 2026. | nse |
| 17 Mar, 04:39 pm | — | … | Senores Pharmaceuticals Limited has informed the Exchange regarding Resignation of Senior Management Personnel of the Company | nse |
| 17 Mar, 04:39 pm | — | … | Senores Pharmaceuticals Limited has informed the Exchange regarding Appointment of Senior Management Personnel of the Company | nse |
| 12 Mar, 07:06 pm | — | … | Senores Pharmaceuticals Ltd - 544319 - Revised Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011. | bse |
| 09 Mar, 04:35 pm | — | … | Senores Pharmaceuticals Limited has informed the Exchange regarding Analyst/Institutional Investor meet scheduled to be held on March 12, 2026. | nse |
| 03 Mar, 03:06 pm | — | … | Senores Pharmaceuticals Limited has informed the Exchange regarding issuance of Corporate Guarantee for the credit facilities availed by Senores Pharmaceuticals Inc. USA, Wholly Owned Subsidiary of the Company from HDFC Bank Limited. | nse |
| 03 Mar, 03:05 pm | — | … | Senores Pharmaceuticals Ltd - 544319 - Announcement Under Regulation 30 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015 | bse |
| 03 Mar, 03:00 pm | — | … | Senores Pharmaceuticals Limited has informed the Exchange regarding issuance of Corporate Guarantee for the additional credit facilities availed by Havix Group Inc. D/B/A Aavis Pharmaceuticals a material subsidiary of the Company from HDFC Bank Limited. | nse |
| 03 Mar, 02:56 pm | — | … | Senores Pharmaceuticals Ltd - 544319 - Announcement Under Regulation 30 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015 | bse |
| 02 Mar, 03:26 pm | — | … | Senores Pharmaceuticals Limited has informed the Exchange regarding Analyst/Institutional Investor meet scheduled to be held on March 09, 2026. | nse |
| 02 Mar, 03:21 pm | — | … | Senores Pharmaceuticals Limited has informed the Exchange regarding Analyst/Institutional Investor meet scheduled to be held on March 06, 2026. | nse |
| 17 Feb, 11:59 am | — | … | Senores Pharmaceuticals Ltd - 544319 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011. | bse |
| 17 Feb, 11:58 am | — | … | Senores Pharmaceuticals Ltd - 544319 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011. | bse |
| 17 Feb, 10:29 am | — | … | Senores Pharmaceuticals Ltd - 544319 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011. | bse |
| 17 Feb, 10:28 am | — | … | Senores Pharmaceuticals Ltd - 544319 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011. | bse |
| 13 Feb, 05:54 pm | — | … | Senores Pharmaceuticals Limited has informed the Exchange regarding additional disclosures to the Notice of Extra-Ordinary General Meeting dated January 07, 2026. | nse |
| 13 Feb, 05:53 pm | — | … | Senores Pharmaceuticals Ltd - 544319 - Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 | bse |
| 04 Feb, 03:25 pm | — | … | Senores Pharmaceuticals Limited has informed the Exchange regarding additional disclosures to the Notice of Extra-Ordinary General Meeting dated January 07, 2026. | nse |
| 04 Feb, 03:23 pm | — | … | Senores Pharmaceuticals Ltd - 544319 - Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 | bse |
| 27 Jan, 06:17 pm | — | … | Senores Pharmaceuticals Limited has informed the Exchange regarding the transcript of Earnings Conference Call held on Tuesday, January 20, 2026 for Q3FY26 | nse |
| 27 Jan, 06:15 pm | — | … | Senores Pharmaceuticals Ltd - 544319 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript | bse |
| 21 Jan, 11:29 am | — | … | Senores Pharmaceuticals Limited has informed the Exchange regarding copy of Newspaper Publication for extracts of Unaudited Standalone and Consolidated Financial Results of the Company for quarter and nine months ended December 31, 2025. | nse |
| 20 Jan, 07:02 pm | — | … | Senores Pharmaceuticals Limited has informed the Exchange regarding audio recordings of Earnings Conference Call for the quarter and nine months ended December 31, 2025. | nse |
| 20 Jan, 07:00 pm | — | … | Senores Pharmaceuticals Ltd - 544319 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome | bse |
| 20 Jan, 05:29 pm | — | … | Senores Pharmaceuticals Limited has informed the Exchange about statement of deviation(s) or variation(s) under Reg. 32 | nse |
| 20 Jan, 05:27 pm | — | … | Senores Pharmaceuticals Ltd - 544319 - Submission Of Statement Of Deviation Or Variation In Utilisation Of Funds Of Public Issue For Quarter Ended On December 31, 2025 | bse |
| 20 Jan, 05:26 pm | — | … | Senores Pharmaceuticals Ltd - 544319 - Submission Of Statement Of Deviation Or Variation In Utilisation Of Funds Of Public Issue For Quarter Ended On December 31, 2025 | bse |
| 20 Jan, 03:33 pm | — | … | Senores Pharmaceuticals Limited has informed the Exchange regarding Monitoring Agency Report for the quarter ended December 31, 2025. | nse |
| 20 Jan, 03:30 pm | — | … | Senores Pharmaceuticals Ltd - 544319 - Announcement under Regulation 30 (LODR)-Monitoring Agency Report | bse |
| 20 Jan, 03:25 pm | — | … | Senores Pharmaceuticals Limited has informed the Exchange about Investor Presentation | nse |